Literature DB >> 12048116

Cellular cholesterol flux studies: methodological considerations.

G H Rothblat1, M de la Llera-Moya, E Favari, P G Yancey, G Kellner-Weibel.   

Abstract

Reverse cholesterol transport (RCT) is the process in which peripheral cells release cholesterol to an extracellular acceptor such as high-density lipoprotein (HDL) which then mediates cholesterol delivery to the liver for excretion. RCT represents a physiological mechanism by which peripheral tissues are protected against excessive accumulation of cholesterol. The first step in RCT is the interaction of the cell with lipoprotein particles, a process that results in both the cellular uptake and release of cholesterol. The various components of this cholesterol flux can be viewed as efflux, influx and net flux. Experimental protocols for measuring each of these components of cholesterol flux are very different, and a number of considerations are required to design experimental approaches for the quantitation of flux parameters. Although many flux studies have been conducted in the past, the recent discoveries of the scavenger receptor B1 (SR-B1) and ATP binding cassette 1 (ABCA1), which mediate the movement of cholesterol between cells and extracellular acceptors, has led to increased interest in studies of cellular cholesterol flux. The aim of this review is to present a discussion of the methodological considerations that should be evaluated during the design and analysis of cellular cholesterol flux experiments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048116     DOI: 10.1016/s0021-9150(01)00713-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  27 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol.

Authors:  Sandhya Sankaranarayanan; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; Bela F Asztalos; Robert Bittman; George H Rothblat
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

3.  HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.

Authors:  Mark S Borja; Kit F Ng; Angela Irwin; Jaekyoung Hong; Xing Wu; Daniel Isquith; Xue-Qiao Zhao; Bryan Prazen; Virginia Gildengorin; Michael N Oda; Tomáš Vaisar
Journal:  J Lipid Res       Date:  2015-08-07       Impact factor: 5.922

4.  Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis.

Authors:  Ginny L Weibel; Denise Drazul-Schrader; Debra K Shivers; Alisha N Wade; George H Rothblat; Muredach P Reilly; Margarita de la Llera-Moya
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-07       Impact factor: 8.311

5.  Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.

Authors:  Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; Ilia V Fuki; Dominic S Ng; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

6.  Novel in vivo method for measuring cholesterol mass flux in peripheral macrophages.

Authors:  Ginny L Weibel; Sara Hayes; Aisha Wilson; Michael C Phillips; Jeffrey Billheimer; Daniel J Rader; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

7.  Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis.

Authors:  Hongliang He; Quan Yuan; Jinghua Bie; Ryan L Wallace; Paul J Yannie; Jing Wang; Michael G Lancina; Olga Yu Zolotarskaya; William Korzun; Hu Yang; Shobha Ghosh
Journal:  Transl Res       Date:  2017-11-21       Impact factor: 7.012

8.  Silencing carboxylesterase 1 in human THP-1 macrophages perturbs genes regulated by PPARγ/RXR and RAR/RXR: down-regulation of CYP27A1-LXRα signaling.

Authors:  Lee C Mangum; Xiang Hou; Abdolsamad Borazjani; Jung Hwa Lee; Matthew K Ross; J Allen Crow
Journal:  Biochem J       Date:  2018-02-09       Impact factor: 3.857

9.  Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages.

Authors:  J Allen Crow; Brandy L Middleton; Abdolsamad Borazjani; M Jason Hatfield; Philip M Potter; Matthew K Ross
Journal:  Biochim Biophys Acta       Date:  2008-08-05

Review 10.  Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol.

Authors:  Yvonne Lange; Theodore L Steck
Journal:  Prog Lipid Res       Date:  2008-03-29       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.